Mouse Study Finds Two Divergent Brain Signatures in Autism Models
An analysis of over 1,000 mouse brain transcriptomes found that different autism-linked mutations can converge into two groups with opposite gene-activity patterns. The groups differed in synaptic communication, RNA processing, chromatin regulation, sex effects, and responses to experimental drugs.
Autism has been tied to over 1,200 risk genes, making it hard to find common biology when mutations are studied one at a time. This work examined RNA activity in prefrontal cortex from 17 engineered mouse lines, including males and females, plus roughly one million single-cell nuclei from 205 mice.
Across more than 1,000 brain transcriptomes, analyses of gene activity, RNA splicing, and co-expression networks split the models into two opposing molecular states. Synaptic signaling genes were lower in Group 1 and higher in Group 2, while RNA-processing and chromatin-related genes showed the reverse. Drug responses also diverged.
This finding may shape how autism research classifies heterogeneous mutations, potentially helping scientists design studies that account for sex and molecular subtype. If similar patterns hold in people, future experimental treatments could be matched to biological profiles rather than diagnosis alone, though mouse models cannot establish clinical benefit. Families, clinicians, and drug developers may gain a framework for interpreting why responses vary, but any societal impact would depend on replication and translation.